Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio Key International (BKYI) Net Margin (2016 - 2025)

Bio Key International's Net Margin history spans 16 years, with the latest figure at 62.26% for Q3 2025.

  • For Q3 2025, Net Margin fell 2781.0% year-over-year to 62.26%; the TTM value through Sep 2025 reached 67.34%, up 519.0%, while the annual FY2024 figure was 62.06%, 4783.0% up from the prior year.
  • Net Margin for Q3 2025 was 62.26% at Bio Key International, up from 68.8% in the prior quarter.
  • Across five years, Net Margin topped out at 23.39% in Q1 2024 and bottomed at 283.35% in Q4 2022.
  • The 5-year median for Net Margin is 88.28% (2022), against an average of 104.45%.
  • The largest annual shift saw Net Margin surged 62153bps in 2021 before it plummeted -10478bps in 2022.
  • A 5-year view of Net Margin shows it stood at 217.02% in 2021, then plummeted by -31bps to 283.35% in 2022, then surged by 54bps to 130.01% in 2023, then grew by 27bps to 94.68% in 2024, then skyrocketed by 34bps to 62.26% in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Net Margin are 62.26% (Q3 2025), 68.8% (Q2 2025), and 45.83% (Q1 2025).